Not exact matches
Approved treatments included
gene therapies and the first new
drugs for rare diseases in many years.
On August 30, the U.S. Food and
Drug Administration
approved a novel
gene therapy for patients with a rare type of leukemia.
AAV is in use in many late - stage clinical trials in the United States, and has already been
approved for use in one
gene therapy drug in the European Union.
In science news around the world, NASA's Cassini mission is about to take its final plunge into the atmosphere of Saturn after 13 years providing an unprecedented view of the planet and its moons, a fight over whether to preserve or develop of one Europe's oldest gold mining sites heats up again, the U.S. Food and
Drug Administration
approves the first cancer
gene therapy for people, a U.S. court gives a green light to a $ 1 billion lawsuit brought by the Guatemalan victims and survivors of mid — 20th century syphilis experiments by research institutions including Johns Hopkins University, and more.
«Rare genetic cause of peritoneal mesothelioma points to targeted
therapy: Genetic rearrangement in the ALK
gene found in young women with mesothelioma may be targetable with FDA -
approved drugs.»
So far, the Food and
Drug Administration has not
approved any human
gene -
therapy product for sale, but the day is coming.
Finally, iCAGES matches the variants to FDA -
approved and experimental
drug therapies that specifically address those variants or
genes.
It uses a virus already
approved by the Food &
Drug Administration for other genetic
therapies in the eye; it delivers an ion channel
gene similar to one normally found in humans, unlike others that employ
genes from other species; and it can easily be reversed or adjusted by supplying new chemical photoswitches.
The authors expect the federal Food and
Drug Administration (FDA) will
approve at least one
gene therapy treatment within the next three years.
This led the team to package the
gene editing tool into AAV, used in late - phase clinical trials in the U.S. and also already
approved in a
gene therapy drug in the European Union.
The first
gene therapy drug was
approved on the Russian market on December 7.
The U.S. Food and
Drug Administration on Aug. 30
approved the first - ever
gene therapy to treat children and young adults with leukemia.
With the currently
approved FDA cancer therapeutics
drugs, we are only targeting the tip of the iceberg (85 targeted
therapies for 105
gene products (1)-RRB- and with over 22,000
genes in our genome many
genes are being neglected!